Liberty Mutual Group Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-8,783
Closed -$1.02M – 171
2018
Q3
$1.02M Hold
8,783
– – 0.02% 372
2018
Q2
$1.11M Buy
8,783
+96
+1% +$11.7K 0.03% 330
2018
Q1
$940K Sell
8,687
-2,511
-22% -$278K 0.03% 406
2017
Q4
$1.23M Buy
+11,198
New +$1.12M 0.04% 360

Other funds holding CLB

Liberty Mutual Group Asset Management's CLB Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 8,783 shares — an estimated $1.02M sold.

Liberty Mutual Group Asset Management first reported a position in CLB in Q4 2017 and held it in 4 quarters. The position peaked at $1.23M in Q4 2017. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 8,783 Core Laboratories shares in Q4 2018, an estimated $1.02M.
  • Liberty Mutual Group Asset Management first reported a position in Core Laboratories in Q4 2017 and held it in 4 quarters.
  • Liberty Mutual Group Asset Management's Core Laboratories position peaked at $1.23M in Q4 2017.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.